Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military
development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and
timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a
timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a
timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA
in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical
development activities may not be completed on time or at all; the results of our clinical
development activities may not be positive, or predictive of real - world results or of results
in subsequent clinical trials; regulatory submissions may not occur or be submitted
in a
timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction
in payment rate or reimbursement for the company's products or an increase
in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors»
in the company's most recent Annual Report on Form 10 - K and
in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
It's a
timely lesson
in the crucial importance of timing: no new technology — not even the coolest
development — will go big if users aren't out of the «this kind of creeps me out» zone.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions
in the industries and markets
in which United Technologies and Rockwell Collins operate
in the U.S. and globally and any changes therein, including financial market conditions, fluctuations
in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand
in construction and
in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges
in the
development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies
in connection with the pending Rockwell Collins acquisition, and capital spending and research and
development spending, including
in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including
in connection with the proposed acquisition of Rockwell; (7) delays and disruption
in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes
in political conditions
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate, including the effect of changes
in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates
in the near term and beyond; (16) the effect of changes
in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result
in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a
timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including
in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted
in their operation of their businesses while the merger agreement is
in effect; (21) risks relating to the value of the United Technologies» shares to be issued
in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition
in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result
in increased inventory and reduced orders as we experience wide fluctuations
in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result
in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations
in customer demand and capacity, including bringing on additional capacity on a
timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs
in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those
in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting
in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting
in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty
in global economic conditions, infrastructure
development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete
development and commercialization of products under
development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid
development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed
in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a
timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further
development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
With the impending adoption of the new Sustainable
Development Goals
in September, this theme could hardly be more
timely.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a
timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic
developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry (R) World (TM); risks related to the collection, storage, transmission, use and disclosure of confidential and personal information;
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a
timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic
developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities
in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties
in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
If we can not proportionately decrease our cost structure (apart from research and
development expenses) on a
timely basis
in response to competitive price pressures, our gross margin and, therefore, our profitability could be adversely affected.
Kurt Zouma is much further along
in his own
development yet will look to make up for lost time at Stoke City this term as he continues to recover from a torn cruciate ligament, and his display at home to Arsenal on Saturday will have given everyone a
timely reminder of the mammoth potential he possesses.
Understanding infant social and emotional
development in the context of maternal mental illness is a
timely and urgent issue.
Demonstrated leadership and project management skills, including effective and supportive supervision of staff,
development of vision and strategy for program, and ability to juggle multiple priorities and respond to emergent situations
in a
timely and effective manner.
She / he carries the initiative to ensure that decisions and policies of the Conference are developed and executed
in a
timely way
in personnel matters, pedagogical matters including program
development, student well - being and discipline, and family relations with the school.
The bond was established as an incentive to complete construction
in a
timely manner, according to John Said, director of community
development.
Development of a review board is critical to facilitating
timely data analysis
in order to develop actionable prevention strategies.
In his welcome address, the host Governor, Mr. Ayodele Fayose who described the meeting which aimed at fostering unity in the southwest states as timely, said it is high time to jettison socio - political and economic differences so as to promote regional integration and developmen
In his welcome address, the host Governor, Mr. Ayodele Fayose who described the meeting which aimed at fostering unity
in the southwest states as timely, said it is high time to jettison socio - political and economic differences so as to promote regional integration and developmen
in the southwest states as
timely, said it is high time to jettison socio - political and economic differences so as to promote regional integration and
development.
Liu has also not stopped putting out audits of city agencies, recently taking the city Economic
Development Corp. to task for mishandling contracts, the city Parks Department for not making repairs
in a
timely manner and the management of a 911 call center for an inflated budget and growing timeline.
Buhari said the various meetings held with Nigerian youths since his arrival
in the country were most
timely as the country was already exploring opportunities to spur
development through entrepreneurship.
Since 1976, AAAS has published an annual report analyzing research and
development in the proposed federal budget
in order to make available to the scientific and engineering communities and to policymakers
timely and objective information about the Administration's plans for the coming fiscal year.
Since 1976, AAAS has published an annual report analyzing research and
development (R&D)
in the proposed federal budget
in order to make available to the scientific and engineering communities and to policymakers
timely and objective information about the Administration's plans for the coming fiscal year.
Nonetheless, the research team suggests that keeping an eye out for the
development of these mutations
in humans infected with H7N9 could help trigger a
timely response to prevent potential spread.
With good foresight and strategic planning, it could develop into a premier regional center for the study of drug response
in Asians — a
timely development toward better therapeutics for at least a third of the world's population.
The Jan. 12 issue of the journal Science provides an
in - depth and
timely review of the key
developments that have led to several successful gene therapy treatments for patients with serious medical conditions.
Spanning the chemistry demands from late discovery / early
development through to product launch and beyond, our experience enables a scientifically unbiased consultative approach
in order to deliver
timely process
development solutions.
«By participating
in this international collaboration, we gained that access, allowing us to generate
timely information on the
development of medical countermeasures to the Ebola outbreak.»
The proceeds of the 5K Hot Trot are directed to providing scholarships, professional education resources, efforts addressing technologist certification and training standards, recognition
in the workplace of technologist competencies, leadership
development programs, and professional forums for presentations and discussion of
timely topics along with networking.
NIH assures that research resources developed with public funds become readily available to the broader research community
in a
timely manner for further research,
development, application, and secondary data analysis
in the expectation that this will lead to products and knowledge of benefit to the public health.
However, they said the
development of the vaccine was
timely, amid concerns the H5N1 bird flu strain circulating
in south east Asia could mutate into a pandemic strain which would put millions of lives at risk.
The authors warned that obesity has become a public health crisis
in the U.S.
Timely, dramatic and effective
development and implementation of corrective programs and policies are needed to avoid the otherwise inevitable health and societal consequences implied by their projections.
New York, NY About Blog Renal & Urology News publishes
timely news coverage of scientific
developments of interest to nephrologists and urologists, including
in - depth coverage of all relevant medical conferences.
About Site - Renal & Urology News publishes
timely news coverage of scientific
developments of interest to nephrologists and urologists, including
in - depth coverage of all relevant medical conferences.
This is a
timely development, as cash strapped western governments reduce the amount of money they dedicate to international aid, and consumers show signs that they increasingly expect the brands they buy from to be ethically conscious, the changing funding environment around NGOs will make the role of businesses
in achieving the goals fundamental.
Execute
development of initial seasonal design category
in context of larger assortment and cost structure; devise style plans and design according to sales needs and emerging trends; ensure
timely execution of product
development calendar
JEPP Online provides
timely information about
developments of the journal and is committed to improve the accessibility and visibility of scholarship published
in JEPP, allowing academics and policy - makers alike to benefit from first - class research focusing on the dynamics of public policy
in Europe.
InnoVal Systems Solutions specializes
in timely and cost - effective
development of enterprise software solutions for workstation Jackpot Slots Mailer - Games Slots Golden Tour - Online Casino No Deposit Bonus Uk - Live Casino Malaysia
Because an efficient process that facilities your involvement at regular intervals can reduce your course
development time by many folds and thereby ensure the
timely rollout of eLearning
in your organization without any last minute surprises.
Also included
in the book — to help explain why kids might be doing what they are doing — is
timely research and data about adolescent physical and emotional
development.
Recent
developments in Data Protection legislation have led us to do a major internal review, and we felt it was
timely to have a proper test of our security posture.
The
development and education program targeted improvement
in a few critical behaviors such as
timely communication, cross-functional team building, teamwork, and problem - solving behaviors.
The report released on 2 February comes
timely as discussions on how to expand water monitoring
in the Post-2015
Development Agenda are underway.
If a country finds a way to meet the basic needs of women by taking loans that the whole society must pay, but the national constitution, and the various policies and services do not show the
timely commitment for equity and equality, the chance to eradicate poverty and hunger will only be about the alleviation of these two major indicators of real
development and sustainability It is then urgent and important not to fall
in such a trap, which only comes to add to the financial and economic indebtedness of the society, and nations, to say the least, and to maintain the system of inequality and impoverishment as it basically exist..
States must identify schools for comprehensive or targeted support by the beginning of the school year
in order to ensure prompt notification to parents and
timely development of school improvement plans.
Deliver feedback
in a
timely fashion and tie it to meaningful and targeted professional
development opportunities.
Talent
Development Secondary encourages effective distributed leadership so that those
in the school closest to the everyday realities of students and staff have the discretion and responsibility to make
timely decisions on their behalf.
Divisions are required to engage
in timely and meaningful consultation with private school officials during the design and
development of their Title II, Part A programs,
in order to provide for the equitable participation of private school teachers and other personnel
in Title II, Part A, equitable services.
Divisions LEA must engage
in timely and meaningful consultation with private school officials during the design and
development of their Title III, Part A, programs and prior to making any decision that may affect the participation of private school students, their teachers, and / or other educational personnel
in Title III, Part A, equitable services.
School leaders can influence the quality of teaching
in their schools
in many ways, including by providing relevant and
timely professional
development for teachers.
A scholarly and historical perspective on educational planning is
timely in light of recent debates about its shortcomings
in the age of the Sustainable
Development Goals.
Principals who report spending the most time on instructional leadership also say that they have access to
timely and accurate student data, professional
development through their district and autonomy
in decision - making.